HomeCompareAELTF vs JNJ

AELTF vs JNJ: Dividend Comparison 2026

AELTF yields 2000000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AELTF wins by $1.6247481716182984e+23M in total portfolio value
10 years
AELTF
AELTF
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6247481716182984e+23M
Annual income
$147,608,011,402,949,780,000,000,000,000.00
Full AELTF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AELTF vs JNJ

📍 AELTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAELTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AELTF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AELTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AELTF
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$125,466,809,692,507,310,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, AELTF beats the other by $125,466,809,692,507,310,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AELTF + JNJ for your $10,000?

AELTF: 50%JNJ: 50%
100% JNJ50/50100% AELTF
Portfolio after 10yr
$8.123740858091492e+22M
Annual income
$73,804,005,701,474,890,000,000,000,000.00/yr
Blended yield
90.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AELTF
No analyst data
Altman Z
0.9
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AELTF buys
0
JNJ buys
0
No recent congressional trades found for AELTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAELTFJNJ
Forward yield2000000.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-50%5.8%
Portfolio after 10y$1.6247481716182984e+23M$20.0K
Annual income after 10y$147,608,011,402,949,780,000,000,000,000.00$827.78
Total dividends collected$1.6146053563276882e+23M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AELTF vs JNJ ($10,000, DRIP)

YearAELTF PortfolioAELTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$100,010,700$100,000,000.00$10,676$355.77+$100.00MAELTF
2$467,446,731,075$467,339,719,626.17$11,407$389.39+$467446.72MAELTF
3$1,021,215,363,816,662$1,020,715,195,814,411.90$12,198$426.53+$1021215363.80MAELTF
4$1,043,112,617,104,109,200$1,042,019,916,664,825,300.00$13,056$467.62+$1043112617104.10MAELTF
5$498,482,143,759,731,400,000$497,366,013,259,430,040,000.00$13,987$513.12+$498482143759731.38MAELTF
6$111,599,275,650,097,780,000,000$111,065,899,756,274,860,000,000.00$14,998$563.56+$111599275650097776.00MAELTF
7$11,738,678,336,351,557,000,000,000$11,619,267,111,405,953,000,000,000.00$16,098$619.52+$11738678336351557632.00MAELTF
8$583,674,362,697,175,100,000,000,000$571,113,976,877,278,900,000,000,000.00$17,295$681.69+$583674362697175072768.00MAELTF
9$13,894,210,989,607,547,000,000,000,000$13,269,679,421,521,570,000,000,000,000.00$18,599$750.82+$1.3894210989607547e+22MAELTF
10$162,474,817,161,829,840,000,000,000,000$147,608,011,402,949,780,000,000,000,000.00$20,022$827.78+$1.6247481716182984e+23MAELTF

AELTF vs JNJ: Complete Analysis 2026

AELTFStock

Adacel Technologies Limited develops and sells air traffic management, air traffic control simulation, and training systems and services for the military and civil sectors primarily in the United States, Canada, Estonia, and Australia. It operates through Systems and Services segments. The Systems segment is involved in the sale of advanced systems, technical software, and hardware. The Services segment includes development and support, and field technical services. The company also offers Aurora air traffic management (ATC) solution for providing oceanic, procedural, and mixed surveillance airspace control; MaxSim air traffic simulator training system; AeroDrive, an immersive training simulator to train airport drivers in a 3-D environment; and intelligent communications environment, an aviation phraseology training tool for air traffic controllers and pilots. In addition, it provides REVAL virtual ATC tower system that delivers digital tower operational solutions. The company was founded in 1987 and is headquartered in Port Melbourne, Australia.

Full AELTF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AELTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AELTF vs SCHDAELTF vs JEPIAELTF vs OAELTF vs KOAELTF vs MAINAELTF vs ABBVAELTF vs MRKAELTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.